Luminate Medical develops a medical device designed to prevent hair loss during chemotherapy. Luminate Medical recognises that hair is an essential element of personality and self-esteem, and is dedicated to using the latest advances in medical technology to protect this.
ImmTune Therapies is an operator of a cell therapy process intended to cut out complicated biomanufacturing processes. The company's platform brings cell therapies to many, enabling patients to enjoy a reduction in the costs of treatment, which were previously a burden on patients.
Engage Bio is developing mRNA treatments that change cancer cells into production facilities for immunotherapies. With the help of these treatments, the immune system is activated and directed toward the tumour.
Inherent Targeting develops fluorescent contrast agents that target nerves to improve surgical outcomes. The company was founded in 2019 and is headquartered in Portland, Oregon.
Symphony Biosciences company is in charge of orchestrating the immune response in the fight against solid cancers. Symphony primary target is triple-negative breast cancer, for which the best current treatments are toxic chemotherapies that simply do not work: survival is poor.
ImmTune Therapies is an operator of a cell therapy process intended to cut out complicated biomanufacturing processes. The company's platform brings cell therapies to many, enabling patients to enjoy a reduction in the costs of treatment, which were previously a burden on patients.
Current Surgical is a surgical device company that develops precise tools for the treatment of solid tumors. The company was founded in 2020 and has its headquarters in Washington, DC.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.